Evolent Health (EVH) Cost of Revenue (2015 - 2026)

Evolent Health has reported Cost of Revenue for 12 years, with the latest figure at $571.7 million in Q2 2026.

• On a quarterly basis, Cost of Revenue rose 66.21% year-over-year to $571.7 million in Q2 2026; TTM through Jun 2026 was $1.7 billion, a 5.51% decrease from a year earlier, with the FY2025 full-year figure at $1.5 billion, down 32.51% from the prior year.
• Cost of Revenue was $571.7 million for Q2 2026 at Evolent Health, up from $412.5 million in the prior quarter.
• The five-year high for Cost of Revenue was $571.7 million in Q2 2026, with the low at $219.7 million in Q1 2022.
• Average Cost of Revenue over 5 years is $399.3 million, with a median of $380.5 million recorded in 2025.
• The sharpest annual moves came in 2022 and 2025: Cost of Revenue soared 82.01% in 2022, then tumbled 36.34% in 2025.
• Over 5 years, Cost of Revenue stood at $299.4 million in 2022, then jumped by 51.8% to $454.4 million in 2023, then advanced by 25.62% to $570.8 million in 2024, then tumbled by 34.93% to $371.5 million in 2025, then surged by 53.9% to $571.7 million in 2026.
• The last three Cost of Revenue figures came in at $571.7 million (Q2 2026), $412.5 million (Q1 2026), and $371.5 million (Q4 2025), per Business Quant data.